In New Zealand one in seven children and one in eight adults need to take medicine for asthma. And sadly 96 people die from Asthma in New Zealand each year. Our next guest is developing a device he ...

UCLA Health researchers will present 23 studies at the ASTRO 2024 meeting, showcasing advancements in lung cancer, pediatric ...

Arthritis and asthma victims, and all other users of ACTH, got some good news from Armour Laboratories last week. Highly purified "HP ACTHAR Gel" brings quicker relief than older forms ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...

Regeneron (REGN) and Sanofi's (SNY) asthma therapy Dupixent receives FDA approval for label expansion in treating certain ...

Over the past decade, rates of preterm birth in the United States jumped more than 10%, a new study of more than 5 million ...

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...

During the seventh annual Igniting Hope conference on Sept. 21, one message was made clear: Now is the time to confront health disparities rooted in environmental injustice.

The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...

New research shows that infants who were exclusively fed breast milk during their hospitalization right after birth were 22% ...